Modified conditioning regimen with chidamide and high‐dose rituximab for triple‐hit lymphoma
Modified conditioning regimen with chidamide and high‐dose rituximab for triple‐hit lymphoma
About this item
Full title
Author / Creator
Kang, Junnan , Zhang, Yizhuo , Ding, Sa , Yasheng, Kalbinur , Li, Yueyang , Yu, Yong , Wang, Yafei and Tian, Chen
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Triple‐hit lymphoma (THL), which is classified into high‐grade B‐cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High‐dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto‐HSCT) is considered to be one of the recommended treatment options. Here, we reported 3 THL pa...
Alternative Titles
Full title
Modified conditioning regimen with chidamide and high‐dose rituximab for triple‐hit lymphoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8581337
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8581337
Other Identifiers
ISSN
1582-1838,1582-4934
E-ISSN
1582-4934
DOI
10.1111/jcmm.16999
